Cardiac Imaging: Page 133

Bracco may restart CardioGen sales in 2012
By Wayne Forrest
In an October 17 letter to its customers, contrast agent developer Bracco Diagnostics said that it may be able to resume production of its CardioGen-82 (rubidium-82 chloride injection) PET tracer in the first or second quarter of 2012.
October 18, 2011
InfraReDx touts LipiScan data
By AuntMinnie.com staff writers
Coronary imaging developer InfraReDx said that its LipiScan imaging system can rapidly and accurately detect extensive lipid core plaques that are linked to an increased risk of heart attack during or following percutaneous coronary intervention, according to recent research.
October 17, 2011
FDA clears study for device to prevent CIN
By AuntMinnie.com staff writers
PLC Medical Systems has received final approval from the U.S. Food and Drug Administration to begin its U.S. trial on the efficacy of the company's RenalGuard to prevent contrast-induced nephropathy (CIN).
October 16, 2011
MRI shows cholesterol drug benefits
By AuntMinnie.com staff writers
MRI can help assess how well cholesterol drugs are working to reduce cholesterol in artery-clogging plaque, according to a study by researchers at the University of Washington in Seattle.
October 16, 2011
Handheld US, iPhone app bridge care gap in remote areas
By Erik L. Ridley
Villagers in a remote area of Honduras received access to first-rate echocardiography thanks to a project that married a handheld ultrasound scanner with an iPhone-based image interpretation app. The project could be a model for delivering high-quality imaging to other underserved areas.
October 12, 2011
2011 10 12 14 39 28 308 Choi Thumb
320-row scanner cuts contrast dose in coronary CTA
By Eric Barnes
Contrast media dose can be reduced in coronary CT angiography (CCTA) scans acquired with a 320-detector-row scanner without significantly affecting image quality, according to a study in the October edition of the American Journal of Roentgenology.
October 9, 2011
JACC: CT calcium screening cost-effective only in men
By Eric Barnes
CT-based coronary artery calcium screening in individuals at intermediate risk of heart disease is probably cost-effective for men but not women, according to a new analysis in the October 11 edition of the Journal of the American College of Cardiology.
October 5, 2011
Group files petition over FDA contrast policy
By AuntMinnie.com staff writers
The International Contrast Ultrasound Society has submitted a citizen petition with the U.S. Food and Drug Administration, calling for removal of black box warnings on ultrasound contrast agents.
October 3, 2011
Protocols ensure MRI safety for cardiac device patients
By Wayne Forrest
If a patient with an implanted cardiac device is referred for an MRI scan, can you scan him or her safely? Yes, even if the device is not one of the newer MRI-conditional devices, say cardiologists from Johns Hopkins University in a study published October 4 in Annals of Internal Medicine.
October 3, 2011
2011 10 03 15 59 49 147 Icd Lead In Rv 70
Axess joins with Specialized Technologies
By AuntMinnie.com staff writers
Ultrasound services, training, parts, and probe management firm Axess Ultrasound has merged with transesophageal echocardiography transducer repair firm Specialized Technologies.
October 3, 2011
Maquet parent to buy Atrium Medical
By AuntMinnie.com staff writers
Cardiovascular technology provider Maquet Cardiovascular and its parent Getinge Group have inked a definitive agreement to acquire medical device technology developer Atrium Medical for $680 million.
October 2, 2011
CORE 64: Calcium impedes per-segment diagnosis at CCTA
By Eric Barnes
Does the presence of heavy calcification hinder diagnosis with coronary CT angiography (CCTA)? It surely does, and the more calcium per segment, the greater the inaccuracy, concludes a study in the October issue of Radiology that analyzed data from the recent CORE 64 study.
September 25, 2011
Previous Page
Page 133 of 325
Next Page